Translational Development Acquisition Corp. (NASDAQ:TDACU – Get Free Report) was the target of a significant drop in short interest in September. As of September 30th, there was short interest totaling 3 shares, a drop of 50.0% from the September 15th total of 6 shares. Based on an average daily trading volume, of 16 shares, the days-to-cover ratio is currently 0.2 days.
Translational Development Acquisition Stock Performance
Shares of TDACU remained flat at $11.48 during mid-day trading on Thursday. Translational Development Acquisition has a one year low of $10.71 and a one year high of $17.29. The stock has a 50-day simple moving average of $12.11 and a two-hundred day simple moving average of $11.69.
Translational Development Acquisition Company Profile
Translational Development Acquisition Corporation is a special purpose acquisition company (SPAC) formed to identify and complete a business combination with one or more operating companies. Rather than selling products or services of its own, the company raises capital through a public offering and holds those funds while it evaluates potential merger, acquisition, or similar opportunities.
The company has indicated that it is seeking a target in the healthcare and life sciences sectors, although its business activities may change substantially if it completes a transaction.
Recommended Stories
- Five stocks we like better than Translational Development Acquisition
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
- Fastenal Flashes Bullish Signal as Uptrend Holds Despite Margin Pressure
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
